These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 30167909)

  • 21. Activation of PI3 kinase/Akt/HIF-1α pathway contributes to hypoxia-induced epithelial-mesenchymal transition and chemoresistance in hepatocellular carcinoma.
    Jiao M; Nan KJ
    Int J Oncol; 2012 Feb; 40(2):461-8. PubMed ID: 21922131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer.
    Du B; Shim JS
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27455225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Surgical outcome of biliary tract cancer with postoperative chemotherapy].
    Sugawara G; Ebata T; Yokoyama Y; Igami T; Kokuryo T; Tsunoda N; Fukaya M; Uehara K; Itatsu K; Yoshioka Y; Nagino M
    Gan To Kagaku Ryoho; 2012 Oct; 39(10):1483-5. PubMed ID: 23130375
    [No Abstract]   [Full Text] [Related]  

  • 24. TGF-ß induces Lysyl hydroxylase 2b in human synovial osteoarthritic fibroblasts through ALK5 signaling.
    Remst DF; Blaney Davidson EN; Vitters EL; Bank RA; van den Berg WB; van der Kraan PM
    Cell Tissue Res; 2014 Jan; 355(1):163-71. PubMed ID: 24192939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting Angiogenesis in Biliary Tract Cancers: An Open Option.
    Simone V; Brunetti O; Lupo L; Testini M; Maiorano E; Simone M; Longo V; Rolfo C; Peeters M; Scarpa A; Azzariti A; Russo A; Ribatti D; Silvestris N
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28212293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
    Ma X; Wang B; Wang X; Luo Y; Fan W
    PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Active Wnt signalling is associated with low differentiation and high proliferation in human biliary tract cancer in vitro and in vivo and is sensitive to pharmacological inhibition.
    Kiesslich T; Alinger B; Wolkersdörfer GW; Ocker M; Neureiter D; Berr F
    Int J Oncol; 2010 Jan; 36(1):49-58. PubMed ID: 19956832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PLOD2, a key factor for MRL MSC metabolism and chondroprotective properties.
    Bahraoui S; Tejedor G; Mausset-Bonnefont AL; Autelitano F; Barthelaix A; Terraza-Aguirre C; Gisbert V; Arribat Y; Jorgensen C; Wei M; Djouad F
    Stem Cell Res Ther; 2024 Mar; 15(1):70. PubMed ID: 38454524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of polycomb repressive complexes in biliary tract cancer.
    Mayr C; Neureiter D; Wagner A; Pichler M; Kiesslich T
    Expert Opin Ther Targets; 2015 Mar; 19(3):363-75. PubMed ID: 25424424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapy and histological stratification of biliary tract cancers.
    Cariati A; Piromalli E
    Oncology; 2012; 82(6):352-3. PubMed ID: 22677952
    [No Abstract]   [Full Text] [Related]  

  • 31. Anti-tumor effects of NVP-BKM120 alone or in combination with MEK162 in biliary tract cancer.
    Jin L; Jin MH; Nam AR; Park JE; Bang JH; Oh DY; Bang YJ
    Cancer Lett; 2017 Dec; 411():162-170. PubMed ID: 29024814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exosomes derived from mesenchymal non-small cell lung cancer cells promote chemoresistance.
    Lobb RJ; van Amerongen R; Wiegmans A; Ham S; Larsen JE; Möller A
    Int J Cancer; 2017 Aug; 141(3):614-620. PubMed ID: 28445609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Surgical outcome of biliary tract cancer with neoadjuvant chemotherapy].
    Kato A; Shimizu H; Yoshidome H; Otsuka M; Furukawa K; Yoshitomi H; Takeuchi D; Takayashiki T; Kuboki S; Suzuki D; Nakajima M; Miyazaki M
    Gan To Kagaku Ryoho; 2012 Oct; 39(10):1486-9. PubMed ID: 23133873
    [No Abstract]   [Full Text] [Related]  

  • 34. Biliary tract cancers: molecular profiling as a tool for treatment decisions. A literature review.
    Berardi R; Scartozzi M; Freddari F; Squadroni M; Santinelli A; Bearzi I; Fabris G; Cascinu S
    Cancer Treat Rev; 2006 Aug; 32(5):333-47. PubMed ID: 16762510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2.
    Liao H; Bai Y; Qiu S; Zheng L; Huang L; Liu T; Wang X; Liu Y; Xu N; Yan X; Guo H
    Oncotarget; 2015 Apr; 6(11):8914-28. PubMed ID: 25871397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FGFR signaling maintains a drug persistent cell population following epithelial-mesenchymal transition.
    Brown WS; Akhand SS; Wendt MK
    Oncotarget; 2016 Dec; 7(50):83424-83436. PubMed ID: 27825137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epithelial-mesenchymal transition and drug resistance in breast cancer (Review).
    Huang J; Li H; Ren G
    Int J Oncol; 2015 Sep; 47(3):840-8. PubMed ID: 26202679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ASO Author Reflections: Adjuvant Chemoradiation for Patients with Resected Biliary Tract Cancers.
    Dee EC; Freret ME; Wo JY
    Ann Surg Oncol; 2020 Dec; 27(13):5173-5174. PubMed ID: 32748150
    [No Abstract]   [Full Text] [Related]  

  • 39. Barrier to autointegration factor 1, procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3, and splicing factor 3b subunit 4 as early-stage cancer decision markers and drivers of hepatocellular carcinoma.
    Shen Q; Eun JW; Lee K; Kim HS; Yang HD; Kim SY; Lee EK; Kim T; Kang K; Kim S; Min DH; Oh SN; Lee YJ; Moon H; Ro SW; Park WS; Lee JY; Nam SW
    Hepatology; 2018 Apr; 67(4):1360-1377. PubMed ID: 29059470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting of epidermal growth factor receptor in patients affected by biliary tract carcinoma.
    Leone F; Pignochino Y; Cavalloni G; Aglietta M
    J Clin Oncol; 2007 Mar; 25(9):1145; author reply 1145-6. PubMed ID: 17369582
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.